According to the annual report of the company, there are some strategic projects and initiatives the company undertake that contribute to the company's revenue and profit growth in FY2025: 

1) Acquisition of Monarch Detanl Clinic Limited. The project was completed in February 2025; After the completion, the company's dental service revenue grew 15.9% YoY, the accelerated market penetration in the high-demand dental care segment, created cross referral opportunities with general practice and specialist services. 

2) Specialist services expansion, Polyeye brand development. The company introduced an advanced diagnostic and treatment technologies through the Polyeye brand that provide high margin services. The initiatives enhanced referral pathways between GP clinics and specialist centers within the group. The specialist service became the fastest-growing segment and recorded a reveue surged 23.8% YoY,  

The company delivered resilient 2025 results - with 9.1% revenue growth as well as 8.9% in profit growth underpinned by strategic acquisitions, specialist services expansion and operational discipline. While acknowledging the marco uncertainties and competitive pressures, the Board remains cautiously optimistic, positioning the Group to capture growth opportunites driven by againg demographics, rising health awareness and continued public-private collaboration. 

「註：本人倪國權為證監會持牌人士。截至本評論文章發表日止，本人及 / 或其有聯繫者並無持有全部提及之証券的所有相關財務權益。」 ; Or ” I, Ni Kwok Kuen Alex, am a licensed person under the Securities and Futures Commission. Until the date this commentary was published, neither I and/or my affiliates are the beneficiary of the securities mentioned herein or are entitled to any financial interests in relation thereto. “